Skip to main content
Haemato AG logo

Haemato AG — Investor Relations & Filings

Ticker · HAEK ISIN · DE000A289VV1 LEI · 529900Q3CGRYVCW7E340 F Wholesale and retail trade
Filings indexed 188 across all filing types
Latest filing 2017-10-05 Interim / Quarterly Rep…
Country DE Germany
Listing F HAEK

Haemato AG is a pharmaceutical company focused on the specialty pharma market, concentrating on treatments for chronic diseases and high-priced therapies. The company's business activities include the development, acquisition, licensing, and distribution of a product portfolio that comprises innovative patent-protected medicines, biosimilars, and generics. The portfolio also extends to narcotics, including cannabis products, as well as over-the-counter (OTC) products and special cosmetics. Haemato AG's primary therapeutic areas of focus are HIV/AIDS, neurology, oncology, rheumatology, and ophthalmology.

Recent filings

Filing Released Lang Actions
Half-yearly financial statements 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled '2017 HALF YEAR REPORT' and contains comprehensive financial statements, including a group balance sheet, profit and loss summary, cash flow statement, and interim management report for the period 01.01.2017 to 30.06.2017. It provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). H1 2017
2017-10-05 English
Annual financial statements 2016
Annual Report Classification · 100% confidence The document is titled '2016 ANNUAL REPORT' and contains comprehensive financial statements, a letter to shareholders, a report of the supervisory board, and a consolidated management report for the fiscal year 2016. It provides detailed financial data (balance sheets, income statements) and business analysis, fitting the definition of an Annual Report (10-K). FY 2016
2017-10-05 English
Half-yearly financial statements 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled '2017 HALF YEAR REPORT' and contains comprehensive financial statements, including a group balance sheet, profit and loss summary, cash flow statement, and interim management report for the period 01.01.2017 to 30.06.2017. It provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). H2 2017
2017-10-05 German
Annual financial statements 2016
Annual Report Classification · 100% confidence The document is titled '2016 ANNUAL REPORT' and contains comprehensive financial statements, a letter to shareholders, a report of the supervisory board, and a consolidated management report for the fiscal year 2016. It provides detailed financial data (balance sheets, income statements) and business analysis, fitting the definition of an Annual Report (10-K). FY 2016
2017-10-05 German
Datum:17.01.2017
Annual Report Classification · 100% confidence The document is a German 'Jahresabschluss' (Annual Financial Statement) for HAEMATO AG for the fiscal year 2015. It contains a balance sheet ('Bilanz'), notes to the financial statements ('Anhang'), and detailed accounting policies. As it provides comprehensive financial statements for a full fiscal year, it is classified as an Annual Report (10-K equivalent in the provided taxonomy). FY 2015
2017-01-17 German
Halbjahresabschluss 2016
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ZWISCHENBERICHT 2016' (Interim Report 2016) for HAEMATO AG. It contains comprehensive financial statements (Konzernbilanz, Gesamtergebnisrechnung, Kapitalflussrechnung) for the period 01.01.2016 to 30.06.2016, along with management discussion and analysis (Konzernlagezwischenbericht). It is clearly a semi-annual financial report, not an announcement or a summary. H1 2016
2016-09-14 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.